Literature DB >> 9468285

Pattern of inheritance in hereditary myeloperoxidase deficiency associated with the R569W missense mutation.

W M Nauseef1, M Cogley, S Bock, P E Petrides.   

Abstract

Myeloperoxidase (MPO) is an essential component of the oxygen-dependent microbicidal system of neutrophils and monocytes. Hereditary deficiency of MPO occurs in 1 in 2,000 to 4,000 individuals in the general population and has been generally considered an autosomal recessive trait. Previous studies have used the peroxidase activity of blood leukocytes to assess the phenotype of affected family members. Eosinophil peroxidase (EPO) also contributes to the peroxidase activity of blood leukocytes. Because EPO expression is normal in MPO-deficient subjects, eosinophil contamination can significantly contribute to peroxidase activity in leukocytes from family members of an MPO-deficient subject and thereby undermine correct interpretation of the inheritance pattern. To avoid this potential problem, we used cytochemical, immunochemical, and genetic techniques to assess the inheritance pattern of MPO deficiency in sixteen individuals from five unrelated kindreds. Each kindred had an index case with MPO deficiency and the R569W missense mutation, a genotype that causes MPO deficiency. Our analysis demonstrated that MPO deficiency was not inherited as a simple autosomal recessive trait. Most subjects were compound heterozygotes with respect to the R569W mutation and demonstrated a spectrum of phenotypes. Our data demonstrate the broad phenotypic impact of compound heterozygosity on the expression and function of a multimeric protein such as MPO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468285     DOI: 10.1002/jlb.63.2.264

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  Arginine to cysteine mutation (R499C) found in a Japanese patient with complete myeloperoxidase deficiency.

Authors:  Amanda S Persad; Yosuke Kameoka; Shuji Kanda; Yoshiyuki Niho; Kazuo Suzuki
Journal:  Gene Expr       Date:  2006

3.  Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase.

Authors:  Y Aratani; H Koyama; S Nyui; K Suzuki; F Kura; N Maeda
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Functional consequence of positive selection revealed through rational mutagenesis of human myeloperoxidase.

Authors:  Noeleen B Loughran; Sara Hinde; Sally McCormick-Hill; Kevin G Leidal; Sarah Bloomberg; Sinéad T Loughran; Brendan O'Connor; Ciarán O'Fágáin; William M Nauseef; Mary J O'Connell
Journal:  Mol Biol Evol       Date:  2012-02-21       Impact factor: 16.240

5.  Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.

Authors:  Sunisa Kongkiatkamon; Laila Terkawi; Yihong Guan; Vera Adema; Metis Hasipek; Tatiana Dombrovski; Milo Co; Wencke Walter; Hassan Awada; Yvonne Parker; Stephan Hutter; Simona Pagliuca; Carmelo Gurnari; Heesun J Rogers; Manja Meggendorfer; Daniel J Lindner; Torsten Haferlach; Valeria Visconte; Thomas LaFramboise; Babal K Jha; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2022-06-27       Impact factor: 12.883

Review 6.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

Review 7.  Regulation of innate immunity by NADPH oxidase.

Authors:  Brahm H Segal; Melissa J Grimm; A Nazmul H Khan; Wei Han; Timothy S Blackwell
Journal:  Free Radic Biol Med       Date:  2012-05-01       Impact factor: 7.376

8.  Hyper-truncated Asn355- and Asn391-glycans modulate the activity of neutrophil granule myeloperoxidase.

Authors:  Harry C Tjondro; Julian Ugonotti; Rebeca Kawahara; Sayantani Chatterjee; Ian Loke; Siyun Chen; Fabian Soltermann; Hannes Hinneburg; Benjamin L Parker; Vignesh Venkatakrishnan; Regis Dieckmann; Oliver C Grant; Johan Bylund; Alison Rodger; Robert J Woods; Anna Karlsson-Bengtsson; Weston B Struwe; Morten Thaysen-Andersen
Journal:  J Biol Chem       Date:  2020-12-03       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.